- Case Report
- Open Access
Malignant subdural effusion associated with disseminated adenocarcinoma: a case report
© Mirsadeghi et al; licensee BioMed Central Ltd. 2008
- Received: 05 October 2008
- Accepted: 18 November 2008
- Published: 18 November 2008
Subdural effusion in the setting of dural metastasis is very rare and may be difficult to be distinguished from chronic subdural hematoma.
A 44-year old woman with gastric adenocarcinoma was presented with headache and a hypodense subdural collection in right fronto-parietal in brain CT. Burr-hole irrigation was performed with the impression of chronic subdural hematoma, but nonhemorrhagic xantochromic fluid was evacuated without malignant cell. Brain CT on the 11th day depicted fluid re-accumulation and noticeable midline shift, necessitating craniotomy and removing the affected dura.
Because the affected dura can be supposed as the main source of subdural effusion, resection of the involved dura is obligatory for the appropriate palliative management of such patients.
- Gastric Adenocarcinoma
- Brain Compute Tomography
- Chronic Subdural Hematoma
- Subdural Space
- Subdural Effusion
Subdural effusion may occur following different situations such as bacterial meningitis, head injury and certain surgical procedures such as transventricular approaches or endoscopic third ventriculostomy [1–4]. However, subdural effusion in the setting of dural metastasis is very rare and to our knowledge limited cases have been reported .
In this report, a case of advanced gastric adenocarcinoma with systemic dissemination and metastatic subdural effusion is presented and different aspects regarding diagnosis, treatment and pathophysiology of the lesion, and differentiation from CSH are discussed.
Because of developing dysphasia and worsened hemiparesis during the assessments, re-operation was contemplated and right fronto-parietal craniotomy was performed. A gray-reddish thickened and hyperemic dura was disclosed. The affected dura was resected, and the borders of the dura in the vicinity of the involved region were coagulated carefully.
The patient's headache and other symptoms partially improved post-operatively. During 5 months follow up, serial images showed no evidence of recurrent effusion, nor did the patient experience any other episode of headache. However, the systemic metastatic disease progressed continuously, and the patient died from pulmonary insufficiency.
Dural metastases account for about 3–13% of all intracranial metastatic involvements , with the condition being found in 8–9% of post mortem evaluation of advanced systemic cancers. The most common neoplasms associated with dural metastases are breast cancer, melanoma, gastrointestinal and prostate cancer . The lesions often remain clinically asymptomatic , but they may become symptomatic due to mass effect or developing different kinds of subdural fluid from acute or chronic hematoma to malignant effusion [5, 9, 10]. Chronic subdural hematoma resulting from neoplastic invasion of the meninges is uncommon, with the incidence being about 0.5 – 4% of all intracranial metastases . Metastaic subdural effusion is even scarcer, and to our best knowledge few cases of such condition have been reported beforehand [5, 10].
The differentiation between CSH and subdural effusion due to metastasis in CT scan images is difficult, as the subdural collection may mask the underlying dural involvement . Based on the previous reports, the dural metastasis may have been diagnosed during the second surgery for re-accumulated effusion or hematoma [6, 7, 10]. Since subdural effusion is in the list of differential diagnosis of CSH, more accurate modalities such as MRI can be useful in patients with malignancy and subdural collection to provide a better distinction between non-hemorrhagic fluid and hemorrhagic products. In the present case, regarding the low signal of the collected fluid in T1-weighted and high signal in T-2 weighted images, compatible with cerebrospinal fluid attenuation, the lesion was considered to be effusion rather than hematoma. A better delineation of the probable underlying dural metastasis can be provided by MRI as well. However, MRI would be misleading when the metastasis simulates a meningioma or when the subdural fluid hides the mass . For accurate diagnosis, biopsy of the involved dura and cytological examination is mandatory [6, 7]. Nevertheless, failure to demonstrate neoplastic infiltration dose not necessarily exclude dural metastasis . Moreover, in the most reported cases, no assistance from cytological examination has been revealed [6, 10].
Considering the poor prognosis due to tumor dissemination in most cases, the patients usually undergo palliative treatment. Bur hole irrigation alone is inadequate and may lead to fluid re-accumulation necessitating craniotomy to evacuate the subdural fluid and dura exploration for removing the metastatic tumor . Post-operative irradiation seems to be essential to control the residual neoplastic cells, although the prognosis is poor due to malignant dissemination.
Hypotheses on etiology
Three theories can be postulated concerning the mechanism of subdural fluid accumulation in this case:
1- The fluid extravasation into subdural space may be caused by increased hydrostatic pressure which can be explained by venous or arterial mechanisms. Obstruction of the dural veins by tumor cells would cause dilation of the capillaries in the inner areolar layer [9, 10], followed by increase in capillary transmural pressure and fluid extravasation into subdural space. Moreover, Fukino et al, have shown an increased cerebral blood flow (CBF) in the hemisphere with malignant subdural hematoma . This pattern of altered CBF may exacerbate the fluid collecting process as well.
2- It has been shown that hyperplasia of the inner areolar layer occurs as an angiodesmoplastic response to the tumor invasion . The fluid may be transudated from the immature angiogenesis.
3- Considering the elevated protein content and negative cytology of the fluid, it can be suggested that the mucine producing adenocarcinomatous cells may have potential secretory capability themselves, and the fluid would be originated directly from metastatic malignant cells.
In accordance with all mentioned mechanisms, the involved dura can be supposed as the main source of creating subdural effusion. Consequently, resection of the affected dura can control the effusion.
In conclusion, dural metastasis should be considered in patients with malignant neoplasm and subdural collection. Because the affected dura itself is presumably responsible for fluid production, resection of the involved dura is obligatory for the appropriate palliative management of the metastatic dural effusion.
Written informed consent was obtained from the patient's children for publication of this case report and accompanying images after her death. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Joy HM, Anscombe AM, Gawne-Cain ML: Blood-stained, acute subdural hygroma mimicking a subacute subdural haematoma in non-accidental head injury. Clin Radiol. 2007, 62 (7): 703-6. 10.1016/j.crad.2006.12.010.View ArticlePubMedGoogle Scholar
- Jung TY, Jung S, Jin SG, Jin YH, Kim IY, Kang SS, Kim SH: Prevention of postoperative subdural fluid collections following transcortical transventricular approach. Surg Neurol. 2007, 68 (2): 172-6. 10.1016/j.surneu.2006.10.065.View ArticlePubMedGoogle Scholar
- Kurschel S, Ono S, Oi S: Risk reduction of subdural collections following endoscopic third ventriculostomy. Childs Nerv Syst. 2007, 23 (5): 521-6. 10.1007/s00381-006-0278-1.View ArticlePubMedGoogle Scholar
- Vinchon M, Joriot S, Jissendi-Tchofo P, Dhellemmes P: Postmeningitis subdural fluid collection in infants: changing pattern and indications for surgery. J Neurosurg. 2006, 104 (6 Suppl): 383-7.PubMedGoogle Scholar
- Kamada K, Isu T, Houkin K, Ohsato T, Katoh M, Kojima H: Acute aggravation of subdural effusion associated with pachymeningitis carcinomatosa: case report. Neurosurgery. 1991, 29 (3): 464-6. 10.1097/00006123-199109000-00025.View ArticlePubMedGoogle Scholar
- Tseng SH, Liao CC, Lin SM, Chen Y, Shun CT: Dural metastasis in patients with malignant neoplasm and chronic subdural hematoma. Acta Neurol Scand. 2003, 108 (1): 43-6. 10.1034/j.1600-0404.2003.00080.x.View ArticlePubMedGoogle Scholar
- Kunii N, Morita A, Yoshikawa G, Kirino T: Subdural hematoma associated with dural metastasis – case report. Neurol Med Chir. 2005, 45 (10): 519-22. 10.2176/nmc.45.519.View ArticleGoogle Scholar
- Laigle-Donadey F, Taillibert S, Mokhtari K, Hildebrand J, Delattre JY: Dural metastases. J Neurooncol. 2005, 75 (1): 57-61. 10.1007/s11060-004-8098-1.View ArticlePubMedGoogle Scholar
- Fukino K, Terao T, Kojima T, Adachi K, Teramoto A: Chronic subdural hematoma following dural metastasis of gastric cancer: measurement of pre. and postoperative cerebral blood flow with N-isopropyl-p-[123I]iodoamphetamine – case report. Neurol Med Chir. 2004, 44 (12): 646-9. 10.2176/nmc.44.646.View ArticleGoogle Scholar
- Tasaki K, Shima T, Matsumura S, Okada Y, Nishida M, Yamada T, Okita S, Kagawa R: A case of subdural effusion secondary to dural metastasis of prostatic cancer: case report. No Shinkei Geka. 1990, 18 (6): 539-42.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.